The Brain Tumor Charity recently announced that it had received clearance to conduct a trial to evaluate the effectiveness of a marijuana-based drug in the treatment of recurrent glioblastoma. The general public supported a campaign to raise £400,000 ($532,000) for the charity, which would finance the three-year trial.
The research, which will be led by a University of Leeds expert, will examine whether incorporating the use of an oral spray called Sativex, which contains cannabinoids, in chemotherapy could prolong life for individuals who…
NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma Inc. are available in the company’s newsroom at https://cnw.fm/Sonoma
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Do you have questions or are you interested in working with CNW420? Ask our Editor
CNW420 is part of the InvestorBrandNetwork.